Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12608781rdf:typepubmed:Citationlld:pubmed
pubmed-article:12608781lifeskim:mentionsumls-concept:C0020286lld:lifeskim
pubmed-article:12608781lifeskim:mentionsumls-concept:C0001219lld:lifeskim
pubmed-article:12608781lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:12608781lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:12608781lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:12608781pubmed:issue5lld:pubmed
pubmed-article:12608781pubmed:dateCreated2003-2-28lld:pubmed
pubmed-article:12608781pubmed:abstractTextThe highly stereoselective synthesis of a chiral silylphospholane has been described, which can be advantageously used as a building block under base-free conditions for the construction of diphosphines related to DuPHOS. The utility of silylphospholane is shown in the synthesis of a new bisphospholane ligand 1 (MalPHOS), which is characterized by a maleic anhydride backbone. The ligand forms with Rh(I) a complex with a larger bite angle P-Rh-P than the analogue Me-DuPHOS complex. Both complexes have been tested in the asymmetric hydrogenation of unsaturated alpha- and beta-amino acid precursors of pharmaceutical relevance. In several cases, the new catalyst was superior in comparison to the Me-DuPHOS complex, in particular when (Z)-configured beta-acylamido acrylates were used as substrates.lld:pubmed
pubmed-article:12608781pubmed:languageenglld:pubmed
pubmed-article:12608781pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12608781pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:12608781pubmed:monthMarlld:pubmed
pubmed-article:12608781pubmed:issn0022-3263lld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:SixWWlld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:JiaoHaijunHlld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:FischerChrist...lld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:DrauzKarlhein...lld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:KomarovIgor...lld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:BörnerArminAlld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:MonseesAxelAlld:pubmed
pubmed-article:12608781pubmed:authorpubmed-author:YouJinsongJlld:pubmed
pubmed-article:12608781pubmed:issnTypePrintlld:pubmed
pubmed-article:12608781pubmed:day7lld:pubmed
pubmed-article:12608781pubmed:volume68lld:pubmed
pubmed-article:12608781pubmed:ownerNLMlld:pubmed
pubmed-article:12608781pubmed:authorsCompleteYlld:pubmed
pubmed-article:12608781pubmed:pagination1701-7lld:pubmed
pubmed-article:12608781pubmed:year2003lld:pubmed
pubmed-article:12608781pubmed:articleTitleSynthesis of a new chiral bisphospholane ligand for the Rh(I)-catalyzed enantioselective hydrogenation of isomeric beta-acylamido acrylates.lld:pubmed
pubmed-article:12608781pubmed:affiliationInstitut für Organische Katalyseforschung an der Universität Rostock e.V., Buchbinderstr. 5/6, 18055 Rostock, Germany. jens.holz@ifok.uni-rostock.delld:pubmed
pubmed-article:12608781pubmed:publicationTypeJournal Articlelld:pubmed